文献速递临床试验与 GCP

比较院前急性疼痛管理中吸入甲氧氟烷、鼻内芬太尼与静脉吗啡三种方案的随机对照试验(PreMeFen)研究方案

Comparison of three regimens with inhalational methoxyflurane versus intranasal fentanyl versus intravenous morphine in pre-hospital acute pain management: study protocol for a randomized controlled trial (PreMeFen).
PubMed 文献 · Trials · 2023-09-05

PreMeFen 是一项三臂、随机、对照、非劣效性三期试验,比较吸入甲氧氟烷、鼻内芬太尼与静脉吗啡在院前急性疼痛中的效果。主要终点为用药开始后10分钟疼痛数字评分量表(NRS,0-10分)较基线的变化,非劣效界值设为1.3,计划每组90例、共270例,把握度90%。

要点

  • 研究比较吸入甲氧氟烷、鼻内芬太尼与静脉吗啡三种院前镇痛方案。
  • 主要终点为用药后10分钟NRS评分较基线的变化,非劣效界值1.3。
  • 计划每组90例、共270例,检验把握度为90%。

核心结论

  • PreMeFen 试验旨在确定吸入甲氧氟烷或鼻内芬太尼在院前急性疼痛快速缓解方面是否不劣于静脉吗啡。

研究设计与样本

  • PreMeFen 研究是一项三臂、随机、对照、非劣效性三期试验,比较吸入甲氧氟烷、鼻内芬太尼与静脉吗啡三种镇痛方案。
  • 试验为开放标签设计,按1:1:1随机分配至三个治疗组。
  • 计划样本量为每组90例、共270例,检验把握度为90%。

主要发现

  • 主要终点为用药开始后10分钟疼痛数字评分量表(NRS,0-10分)较基线的变化。
  • 非劣效界值设为1.3。
  • 计划样本量每组90例、共270例,可在此差异下达到90%把握度。

关键数值与推荐

  • 主要终点:用药开始后10分钟NRS评分(0-10分)较基线的变化。
  • 非劣效界值:1.3。
  • 样本量:每组90例、共270例,检验把握度90%。

临床怎么用

  • 作者选择比较镇痛方案而非固定剂量,是因为药物特性差异较大,且结果需对院前决策者有参考价值。
  • 作者认为,若这些方案与现有方案效果相当,更便捷的给药方式将使更多患者获得更好的疼痛管理,因此采用非劣效性设计。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pre-hospital pain management has traditionally been performed with intravenous (IV) morphine, but oligoanalgesia remain a recognized problem. Pain reduction is essential for patient satisfaction and is regarded as a measure of successful treatment. We aim to establish whether non-invasive methods such as inhalation of methoxyflurane is non-inferior to intranasal fentanyl or non-inferior to the well-known IV morphine in the pre-hospital treatment of acute pain. METHOD/DESIGN: The PreMeFen study is a phase three, three-armed, randomized, controlled, non-inferiority trial to compare three regimens of analgesics: inhalation of methoxyflurane and intranasal (IN) fentanyl versus IV morphine. It is an open-label trial with a 1:1:1 randomization to the three treatment groups. The primary endpoint is the change in pain numeric rating scale (NRS) (0-10) from baseline to 10 min after start of investigational medicinal product administration (IMP). The non-inferiority margin was set to 1.3, and a sample size of 270 patients per protocol (90 in each treatment arm) will detect this difference with 90% power. DISCUSSION: We chose a study design with comparison of analgesic regimens rather than fixed doses because of the substantial differences in drug characteristics and for the results to be relevant to inform policymakers in the pre-hospital setting. We recognize that easier administration of analgesics will lead to better pain management for many patients if the regimens are as good as the existing, and hence, we chose a non-inferiority design. The primary endpoint, the change in pain (NRS) after 10 min, is set to address the immediate need of pain reduction for patients with acute prehospital pain. On a later stage, more analgesic methods are often available. PreMeFen is a non-inferiority randomized controlled trial comparing three analgesic regimens aiming to establish whether inhalation of methoxyflurane or intranasal fentanyl is as good as IV morphine for fast reduction of acute pain in the prehospital setting.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Simensen R, Fjose LO, Rehn M, et al. Comparison of three regimens with inhalational methoxyflurane versus intranasal fentanyl versus intravenous morphine in pre-hospital acute pain management: study protocol for a randomized controlled trial (PreMeFen). Trials. 2023. PMID: 37670364. doi:10.1186/s13063-023-07590-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。